ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984

Final Issue Of ‘77

December 16, 1977

BRCA Mutations In About 2% Of Breast Cancer Patients

August 25, 2006

NCI, Komen Foundation Fund Summit meeting On Breast Cancer

October 8, 1993

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

Brachytherapy Better Than Surgery For Prostate Cancer

October 29, 2004